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Abstract
Aims Assess and compare among Dutch cardiothoracic sur-
geons and cardiologists: opinion on (1) patient involvement,
(2) conveying risk in aortic valve selection, and (3) aortic
valve preferences.
Methods and results A survey among 117 cardiothoracic
surgeons and cardiologists was conducted. Group responses
were compared using theMann–Whitney U test. Most respon-
dents agreed that patients should be involved in decision-
making, with surgeons leaning more toward patient involve-
ment (always: 83 % versus 50 % respectively; p<0.01) than
cardiologists. Most respondents found that ideally doctors and
patients should decide together, with cardiologists leaning
more toward taking the lead compared with surgeons
(p<0.01).
Major risks of the therapeutic options were usually
discussed with patients, and less common complications to a
lesser extent. A wide variation in valve preference was noted
with cardiologists leaning more toward mechanical prosthe-
ses, while surgeons more often preferred bioprostheses
(p<0.05).
Conclusion Patient involvement and conveying risk in aortic
valve selection is considered important by cardiologists and
cardiothoracic surgeons. The medical profession influences
attitude with regard to aortic valve selection and patient in-
volvement, and preference for a valve substitute. The variation
in valve preference suggests that in most patients both valve
types are suitable and aortic valve selection may benefit from
evidence-based informed shared decision-making.
Keywords Shared decision-making . Aortic valve
replacement . Aortic valve prostheses
Introduction
For most patients with severe aortic valve disease, aortic valve
replacement is the treatment of choice. For the majority of
patients two options exist: mechanical or bioprosthetic aortic
valve replacement [1]. The decision for a particular prosthetic
valve type is ideally driven by scientific evidence on patient
outcome after implantation with different valve substitutes,
the patient’s clinical state and circumstances, and informed
patient preferences. Each valve type has specific advantages
and disadvantages. Mechanical valves are designed to last a
lifetime, so a lower re-operation hazard can be anticipated,
compared with bioprosthetic valves. However, mechanical
valves carry an increased thrombotic risk and therefore require
lifelong anticoagulation [2]. Clinical characteristics such as
age, anticipated life expectancy, indication/contraindication
for anticoagulation, and comorbidities play an important role
in the decision-making process [3]. Given the different nature
of the pros and cons of different prosthetic valves, informed
patient preferences deserve consideration in the decision-
making. Shared decision-making is receiving more and more
attention in healthcare [4]. Using shared decision-making,
patients are stimulated to think about their treatment, about
treatment options and associated benefits and harm so they
can place these in their own personal context and discuss their
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preferences with the physician and then decide with their
physician what treatment option is best for them [5].
The 2012 ESC/EACTS Valvular Heart Disease Guidelines
state that a mechanical or bioprosthetic valve should be recom-
mended according to the desire of the informed patient [2]. But
how do we inform the patient? And how do we assess patient
preferences? The opinion of Dutch cardiothoracic surgeons and
cardiologists on shared decision-making is as yet undefined [6].
To investigate shared decision-making in daily cardiovascular
practice, we performed this study. The purpose of this study was
to assess the expert opinion of the cardiothoracic surgeon and
cardiologist on patient involvement and conveying risk in aortic
valve selection, and to assess prosthetic aortic valve preferences
of cardiac surgeons and cardiologists.
Methods
A survey was administered to cardiothoracic surgeons (in
training) during the semi-annual meeting of the Netherlands
Association for Cardiothoracic Surgery (November 2011) and
distributed among cardiothoracic surgeons in several institu-
tions (2012). The same survey was administered to cardiolo-
gists (in training) attending the semi-annual meeting of the
Netherlands Society of Cardiology (May 2012) and distribut-
ed among cardiologists in several institutions (2012).
The questionnaire consisted of five general questions: physi-
cian age, speciality (surgeon (in training), cardiologist (in train-
ing)), hospital, number of years in practice, and annual number of
aortic valve replacements in their institution. The physicianswere
asked five questions to assess their opinion on involvement of
patients in decision-making using a Control Preference scale [7,
8] and 5-point Likert scales [6, 9]. Physician perspective on
discussing risks and benefits of different prosthetic valve types
was assessed by rating how often each complication will be
discussed using 5-point Likert scales ranging from never to
always. Physician opinion on choice of treatment strategies was
assessed by six hypothetical cases in which the physician rated
the likelihood of choosing a particular prosthetic valve type using
7-point Likert scales ranging from 1 (definitely mechanical
valve) to 7 (definitely bioprosthetic valve). For a detailed de-
scription of the questionnaire, see Appendix.
Statistical methods
Continuous variables are displayed as mean, standard devia-
tion and range, discrete variables as counts or proportions.
Comparison of group characteristics was done using the un-
paired t-test. Group responses are displayed as median, inter-
quartile range, and total range. To compare group responses
between surgeons and cardiologists and influence of physician
age and cardiac surgery program in the respondent’s institu-
tion on survey response, the Mann–Whitney U-test was used
at a probability value of 0.05. All tests were two-sided, and a
p-value of 0.05 or less was considered statistically significant.
All statistical analyses were performed using IBM-SPSS 20
(IBM Corp., Armonk, NY).
Results
A total of 117 Dutch medical specialists from 38 different
institutions participated. Mean age was 47±10 years (range
26–67), mean clinical experience 14±9 years (range 0–36).
Fifty-four cardiothoracic surgeons (11 in training) represent
38 % of the Dutch cardiothoracic surgeon population, 63 cardi-
ologists (7 in training) represent 6 % of the Dutch cardiologist
population. There were no differences in age and clinical expe-
rience between the cardiothoracic surgeons and cardiologists.
Physician view on patient participation in decision-making
Figure 1 displays physician preferences for patient involve-
ment and the conveying risk. Figure 2 displays physician
preferences for final decision-making in prosthetic aortic
valve choice. Subgroup analysis revealed that physicians
above the age of 50 more often lean toward patient involve-
ment in decision-making than physicians under age 50. Phy-
sicians working in a centre with cardiac surgery were more
inclined to decide together with the patient, while physicians
working in a centre without a cardiac surgery program more
often preferred to take the lead in decision-making.
Physician view on conveying risk and benefit
Figures 3 and 4 summarise physician responses regarding
conveying risk and benefit to patients about mechanical
valves (Fig. 3) and bioprosthetic valves (Fig. 4).
There were no differences between surgeons and cardiolo-
gists regarding conveying risk and benefit to patients. Physi-
cians under the age of 50 more often informed patients re-
garding anticoagulation risks than physicians older than age
50. Physicians working in a centre with cardiac surgery more
often informed patients about the risks and benefits of a
mechanical valve compared with those working in a centre
without a cardiac surgery program.
Physician prosthetic valve preferences
The results of the answers to the six hypothetical patient cases
are illustrated in the box-and-whisker plot in Fig. 5. Physi-
cians above the age of 50 were leaning more toward mechan-
ical valves compared with physicians under age 50. The
presence of a cardiac surgery program in the respondent’s
institution was not associated with prosthetic valve prefer-
ences in any of the six hypothetical cases.
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Discussion
Prosthetic aortic valve selection is a delicate process. By carefully
considering research evidence on outcome after aortic valve
replacement with different aortic valve prostheses, clinical char-
acteristics and medical circumstances of the patient, and by
taking patient preferences into account, the likelihood of making
an optimal choice increases [1]. The results from this survey
among Dutch cardiothoracic surgeons and cardiologists suggest
that patient involvement in prosthetic aortic valve selection is
considered important by most physicians. This finding is in line
with previous research in othermedical professions, showing that
patients and physicians prefer the decision to be the outcome of a
shared decision-making process [8, 10]. Dutch cardiothoracic
surgeons lean more toward patient involvement than cardiolo-
gists, who prefer to take the lead in decision-making, as do
physicians above the age of 50 and physicians who are working
in an institution with a cardiac surgery program. These differ-
ences could be due to external factors in medical prac-
tice, such as differences in consulting time, and cultural
differences. Since shared decision-making has not yet
been standardised in clinical practice, there is probably
a wide variation in the application of the concept in
current clinical practice. Current practice in one hospital
could, for example, be that the surgeons are mainly
discussing the choice for a certain valve type with the
patients, while in another clinic cardiologists do so, or
both specialities together. Although the 2012 ESC/
EACTS Valvular Heart Disease Guidelines state that a
prosthetic valve should be recommended according to the
desire of the informed patient [1], the way Dutch hospi-
tals are following these guidelines probably differs a lot.
The Netherlands Association for Cardiothoracic Surgery
and the Netherlands Society of Cardiology should make
efforts to achieve a more uniform application of the
guidelines in Dutch cardiovascular practice.
Most respondents thought that the physician can often decide
for patients how risks and benefits should be weighed, and how
quality of life should be weighed against life expectancy. It is,
however, doubtful that a physician is actually good at assessing
patient preferences in the context of prosthetic aortic valve
selection. Physician perception of patient preferences in cardio-
vascular practice has not yet been investigated, but previous
studies in the fields of vascular surgery and colorectal cancer
screening have shown that physician perception of patient pref-
erences may differ considerably from actual patient preferences
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Fig. 1 Cardiologist (C) and
surgeon (S) preference for patient
involvement and risk conveyance
in aortic valve selection. Total n=
117, cardiologists=63 and
surgeons=54. Difference between
groups: *p<0.01. Pts=patients.
QoL=quality of life
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Fig. 2 Physician preference for
final decision in prosthetic aortic
valve choice. Total n=117,
cardiologists=63 and surgeons=
54. Difference between
cardiologists and surgeons:
p<0.01
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[11, 12]. In fact, it was shown that although physicians usually
think that they can adequately assess patient preferences, reality
shows that they cannot do this. This is regardless of the clinical
experience they have: from first-year residents to senior regis-
trars, this deficit persists [13]. Because physicians have a major
influence on patient decision-making, it is important for the
physician to realise that their preferences may not be the prefer-
ences of the patient.
Patients who require aortic valve replacement need to be
informed about the risks and benefits associated with the dif-
ferent prosthetic valve types in order to be able to participate in
decision-making. The current study shows that in Dutch car-
diovascular clinical practice major risks of the different thera-
peutic options are usually discussed with patients, and less
common complications to a lesser extent. The observation that
younger physicians more often report informing the patients
regarding anticoagulation risks and that physicians working in
an institution with a cardiac surgery program more often report
informing patients about risks and benefits regarding amechan-
ical prosthesis, reflects the fact that evaluation of the risks and
benefits is a complex process. This complexity is due to uncer-
tainty about the various outcomes, difficulty to evaluate future
events and the fact that most patients are unfamiliar with the
medical consequences of their decisions [1].
The observation that both patient involvement and informa-
tion provision to the patient aremore common in institutionswith
a cardiac surgery program may be associated with the fact that
these institutions have formal heart teams in which the cardiolo-
gists and surgeons discuss prosthetic valve selection.
To make patients more familiar with their treatment options it
is important to inform patients, in a way that they can understand,
about the benefits and risks associated with the different valve
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Fig. 3 Physician responses
regarding risk and benefit
conveyance to patients about
mechanical valves. Total n=117
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Fig. 4 Physician responses
regarding risk and benefit
conveyance to patients about
bioprosthetic valves. Total n=117
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types. Well-informed patients are an essential requirement for
successful shared decision-making.Only then can patients decide
what is best for them and this will result in an optimisation of
valve selection and an improved quality of life [14]. Of course,
patients differ in their information needs. Some patients want to
know every detail of their treatment, while other patients do not
want to be involved at all. Furthermore, the educational level of
the patient plays an important role in shared decision-making. It
is known that incapacity to understand the process of medical
decision-making is common [15]. Despite these differences in
information needs and educational level, it is important that
physicians should at least try to involve the patient. In some
patients, however, this will require a lot of time and effort from
the treating physician. Patient decision aids may be particularly
useful in this setting. A decision aid will provide the patient with
information about the disease, treatment options and risks and
benefits that are associated with the different treatment options.
Additionally, a decision aid helps the patient to place the provid-
ed information in his or her own context, considering the values
and expectations of the patient. It is known that decision aids
improve patient knowledge and lower decisional conflict without
raising anxiety levels [16]. Only when patients are fully informed
about their treatment options can they participate in the decision-
making process and clarify their preferences to the physician.
Although not all patients are willing to participate in decision-
making, it is known that most patients do want to be informed
[17] . Even patients who initially do not want to be involved in
decision-making, do want to be involved once they are well
informed [10, 18].
An important finding of the current study is the observed
wide variation in physician preferences for a particular valve
substitute and the association between medical speciality and
prosthetic valve preferences. It may be that this variation is
caused by differences in clinical practice setting, although we
could not detect a difference between practices with or without
an onsite cardiac surgery program. It may also be that
physicians feel that in most patients both valve types are
suitable. This is supported by the observation that in current
practice there appears to be no difference in survival for adult
patients with a mechanical or a bioprosthesis [19–22]. If the
type of implanted prosthesis is not associated with patient
survival, then the choice for a particular aortic valve prosthesis
is mainly driven by valve-related event occurrence. Given the
completely different nature of valve-related events between
mechanical and bioprostheses, and subjective aspects of
choosing between the hazards of bleeding due to
anticoagulation (mechanical prostheses) and the hazards of
re-operation (biological prostheses), informed patient prefer-
ences become very important.
In conclusion, this survey among Dutch cardiothoracic
surgeons and cardiologists provides important information
on current clinical decision-making regarding prosthetic aortic
valve selection. Dutch cardiovascular professionals are of the
opinion that prosthetic aortic valve selection should be done
with the patient, and they usually convey most risks and
benefits of the different options to the patient. Medical speci-
ality influences both physician attitude with regard to pros-
thetic aortic valve selection and patient involvement, and
preference for a particular valve substitute. The observed wide
variation in prosthetic aortic valve preferences among Dutch
cardiothoracic surgeons and cardiologists suggests that for
most patients both mechanical and bioprosthetic valves are
suitable, and that formal implementation of the concept of
shared decision-making including the use of patient decision
aids may be helpful for physicians and patients to improve
patient information and patient participation in decision-
making.
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Appendix
1. Do you think patients should be involved in choosing an aortic valve? 
Never       Sometimes       Regularly       Often       Always       I don’t know  
2. If a patient doesn’t want to be involved in choosing an aortic valve, do you think that physicians should try to involve 
the patient in the decision? 
Never       Sometimes       Regularly       Often       Always       I don’t know  
3. The final decision in prosthetic aortic valve choice should be made by: 
o The patient 
o The patient, after considering physician opinion 
o The patient and the physician together 
o The physician, after considering patient opinion 
o The physician 
4. To choose a prosthetic aortic valve, the advantages and disadvantages of different prosthetic aortic valve types are 
taken into consideration. Do you think physicians can decide for patients how risks and benefits should be weighed?  
Never       Sometimes       Regularly       Often       Always       I don’t know  
5. Do you think that all disadvantages of a prosthetic aortic valve should be discussed with the patient (even if there is a 
small chance)? 
Never       Sometimes       Regularly       Often       Always       I don’t know  
6. How often do you inform the patient about the following issues regarding a mechanical valve? 
o Anticoagulation lifelong 
Never       Sometimes       Regularly       Often       Always       I don’t know  
o INR control 
Never       Sometimes       Regularly       Often       Always       I don’t know  
o Anticoagulation risks 
Never       Sometimes       Regularly       Often       Always       I don’t know  
o Thrombogenicity 
Never       Sometimes       Regularly       Often       Always       I don’t know  
o Valve sound 
Never       Sometimes       Regularly       Often       Always       I don’t know  
o Re-operation risk 
Never       Sometimes       Regularly       Often       Always       I don’t know  
o Endocarditis risk 
Never       Sometimes       Regularly       Often       Always       I don’t know  
How often do you inform the patient about the following issues regarding a bioprosthetic valve?  
o Re-operation risk 
Never       Sometimes       Regularly       Often       Always       I don’t know  
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